Cipher Pharmaceuticals Inc
SWB:PHE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cipher Pharmaceuticals Inc
SWB:PHE
|
CA |
|
P
|
PowerUp Acquisition Corp
NASDAQ:PWUP
|
US |
Wall St Price Targets
PHE Price Targets Summary
Cipher Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for PHE is 12.49 EUR with a low forecast of 10.6 EUR and a high forecast of 14.27 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHE's stock price target?
Price Target
12.49
EUR
According to Wall Street analysts, the average 1-year price target for PHE is 12.49 EUR with a low forecast of 10.6 EUR and a high forecast of 14.27 EUR.
What is the Revenue forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 3 years is 12%.
What is the Gross Profit forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
20%
The compound annual growth rate for Gross Profit over the next 3 years is 20%.
What is the Operating Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
31%
The compound annual growth rate for Operating Income over the next 1 year is 31%.
What is the Pre-Tax Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
27%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 27%.
What is the Net Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
14%
The compound annual growth rate for Net Income over the next 3 years is 14%.
